RFK Jr's statewide tour promoting his Make America Healthy Again (MAHA) agenda has been called “performative” by a US health consultancy.

Maui Imaging has secured $14m in a Series D financing round, including equity funding, for supporting CET-based imaging technology.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for CardioTag, Cardiosense’s multimodal, wearable sensor.

AdvaMed has praised the CMS' plans to establish a framework to simplify the exchange of healthcare data between patients and providers.

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

Medical device database EUDAMED is viewed by the European Commission as an integral part of the EU MDR and EU IVDR’s implementation.

Johnson & Johnson MedTech has launched the VIRTUGUIDE System, an AI-powered Lapidus solution to minimise bunion surgery complexities.

ALZpath’s pTau217 antibody is drawing significant attention at this year’s Alzheimer's Association International Conference (AAIC), taking place in Toronto, Canada, from 27-31 July. The biomarker ...

GE HealthCare and Ascension have partnered to improve clinical and operational outcomes within the latter’s national network.

AngioDynamics has enrolled the first subject in the AMBITION BTK trial designed to assess the Auryon Atherectomy System.

Olympus and private equity firm Revival Healthcare Capital have co-founded a new endoluminal robotics startup named Swan EndoSurgical Robotics.

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.